High density lipoprotein (HDL) particle composition in patients with end stage renal failure (ESRF) on chronic dialysis

Australian and New Zealand Journal of Medicine

Volumn 27, Issue 3, 1997, Pages 285-293

  Lee, P ^a   O'Neal, D ^a   Murphy, B ^a   Best, J ^a,b  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Cholesterol; Dialysis; End stage renal failure; Insulin resistance; Lipids

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; HEMODIALYSIS; HUMAN; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; KIDNEY FAILURE; LIPID COMPOSITION; MAJOR CLINICAL STUDY; MALE; PARTICLE SIZE; POLYACRYLAMIDE GEL ELECTROPHORESIS; TRIACYLGLYCEROL BLOOD LEVEL; ULTRACENTRIFUGATION;

EID: 0030793398     PISSN: 00048291     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.1997.tb01980.x     Document Type: Article

References (39)

1. Nestel PJ, Fidge NH, Tan MH. Increased lipoprotein remnant formation in chronic renal failure. N Engl J Med 1982; 307: 329-33.
2. O'Neal D, Lee P, Murphy B, Best J. Low density lipoprotein particle size distribution in end-stage renal disease treated with hemodialysis or peritoneal dialysis. Am J of Kidney Dis 1996; 21: 84-91.
3. Shoji T, Nishizawa Y, Nishitani H, Yamakawa M, Morii H. Roles of hypoalbuminaemia and lipoprotein lipase on hyperlipoproteinaemia in continuous ambulatory peritoneal dialysis. Metabolism 1991; 40: 1002-8.
4. Avram MM, Goldwasser P, Burrell D, Antigneni A, Fein P, Mittman N. The uraemic dyslipidaemia: a cross sectional and longitudinal study. Am J Kidney Dis 1992; 20: 324-35.
5. Kandoussi A, Cachera C, Reade R, Pagniez D, Fruchart JC, Tacquet A. Apo AIV n plasma and dialysate fluid of CAPD patients: Comparison with other apolipoproteins. Nephrol Dial Transplant 1992; 7: 1026-9.
6. Coresh J, Kwiterovitch PO, Smith HH, Bachorik PS. Association of plasma triglyceride concentration and LDL particle diameter, density and chemical composition with premature coronary artery disease in men and women. J Lipid Res 1993; 34: 1687-97.
7. Verdery RB, Benham DF, Baldwin HL, Goldberg AP, Nichols AV. Measurement of normative HDL subfraction cholesterol levels by Gaussian summation analysis of gradient gels. J Lipid Res 1989; 30: 1085-95.
8. Blanche PJ, Gong EL, Forte TM, Nichols AV. Characterisation of human high-density lipoproteins by gradient gel electrophoresis. Biochim Biophys Acta 1981; 665: 408-19.
9. Rodbard D, Kappadia G, Chrambach A. Pore gradient electrophoresis. Anal Biochem 1971; 40: 135-57.
10. Li Z, McNamara JR, Ordovas JM, Schaefer EJ. Analysis of high density lipoproteins by a modified gradient gel electrophoresis method. J Lipid R 1994; 35: 1698-711.
11. Lee P, O'Neal D, Murphy B, Best J. The role of abdominal adiposity and insulin resistance in dyslipidaemia of chronic renal failure. Am J Kidney Dis 1997; 29: 54-65.
12. Galvin P, Ward G, Walters J et al. A simple method for quantitation of insulin sensitivity and insulin release from an intravenous tolerance test. Diabetic Med 1992; 9: 921-8.
13. Sniderman A, Cianflone K, Kwiterovich Jr PO, Hutchinson T, Barre P, Prichard S. Hyperapobetalipoproteinaemia: The major dyslipoproteinaemia in patients with chronic renal failure treated with chronic ambulatory peritoneal dialysis. Atherosclerosis 1987; 65: 257-64.
14. Shoji T, Nishizawa Y, Nishitani H, Yamakawa M, Morii H. Impaired metabolism of high density lipoprotein in uraemic patients. Kidney Int 1992; 41: 1653-61.
15. Pollock CA, Wyndham R, Collett P et al. Effects of erythropoietin therapy on the lipid profile in end stage renal failure. Kidney Int 1994; 45: 897-902.
16. Parsy D, Dracon M, Cachera C et al. Lipoprotein abnormalities in chronic haemodialysis patients. Nephrol Dial Transplant 1988; 3: 51-6.
17. Joven J, Rubies-Prat JR J, Espinel E, Chacon P, Olmos A, Masdeu S. Apoprotein AI and high density lipoprotein subfractions in patients with chronic renal failure receiving haemodialysis. Nephron 1985; 40: 451-4.
18. Ohta T, Hattori S, Nishiyama S, Higashi A, Matsuda I. Quantitative and qualitative changes of apolipoprotein AI containing lipoproteins in patients on continuous ambulatory peritoneal dialysis. Metabolism 1989; 38: 843-9.
19. Rubies-Prat J, Espinel E, Joven J, Ras MR, Pira L. High density lipoprotein subfractions in chronic uremia. Am J Kidney Dis 1987; 9: 60-5.
20. Shoji I, Nishizawa Y, Nishitani H, Yamakawa M, Morii H. High serum lipoprotein (a) concentrations in uraemic patients treated with continuous peritoneal dialysis. Clin Nephrol 1992; 38: 271-6.
21. Fievet C, Fruchart JC. HDL heterogeneity and coronary heart disease. Diabetes Metab Rev 1991; 7: 155-62.
22. Salonen JT. Epidemiology of high density lipoproteins and atherosclerosis. In: Carlson LA(Ed.) Disorders of HDL. London: Smith-Gordon, 1990, pp. 145-54.
23. Miller NE. Association of high density subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. Am Heart J 1987; 113: 589-97.
24. Blumenkrantz MJ, Gahl AM, Kopple JD et al. Protein losses during peritoneal dialysis. Kidney Int 1981; 19: 593-602.
25. Steele J, Billington T, Janus ED, Moran J. Lipids, lipoproteins and apolipoproteins Al and B and apoprotein loses in continuous ambulatory peritoneal dialysis. Atherosclerosis 1989; 79: 47-50.
26. Marsh J, Drabkin D. Experimental reconstitution of metabolic pattern of lipid nephrosis: key role of hepatic protein synthesis in hyperlipidaemia. Metabolism 1960; 9: 946-55.
27. Miller NE, Hammett F, Saltissi S. Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins. Br Med J 1981; 282: 1741-4.
28. Godberg AP, Herschel RH, Patsch W et al. Racial differences in plasma high density lipoproteins in patients receiving haemodialysis. A possible mechanism for accelerated atherosclerosis in men. N Engl J Med 1983; 308: 1245-52.
29. Dieplinger H, Shoenfeld PY, Fielding CJ. Plasma cholesterol metabolism in end stage renal disease. Difference between treatment by haemodialysis and peritoneal dialysis. J Clin Invest 1986; 77: 1071-83.
30. McNerney CA, Kashyap ML, Barnhart RL, Jackson RL. Comparison of gradient gel electrophoresis and zonal ultracentrifugation for quantitation of high density lipoproteins. J Lipid R 1985; 26: 1363-7.
31. Johansson J, Carlson LA, Laudon C, Hamsten A. High density lipoproteins and coronary atherosclerosis: a strong inverse relation with the largest particles is confined to normotriglyceridaemic patients. Arteriosclerosis Thrombosis 1991; 11: 174-82.
32. Johansson J, Carlson LA. High density lipoprotein particle size subclass alterations by treatment with nicotinic acid. In: Carlson LA (Ed.). Disorders of HDL. London: Smith-Gordon, 1990:
33. Taskinen MR. Insulin resistance and lipoprotein metabolism. Curr Opin Lipidol 1995; 6: 153-60.
34. Patsch JR, Prasad S, Gotto AM, Patsch W. High density lipoprotein 2: relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipaemia and to the activities of lipoprotein lipase and hepatic lipase. J Clin Invest 1987;80:341-7.
35. Miesenbock G, Patsch JR. Postprandial hyperlipidaemia: The search for the atherogenic lipoprotein. Curr Opin Lipidol 1992; 3: 196-201.
36. Tall A. Plasma high density lipoproteins. J Clin Invest 1990; 86: 379-84.
37. Frayn K. Insulin resistance and lipid metabolism. Curr Opin Lipidol 1993; 4: 197-204.
38. Clay MA, Newham HH, Barter PH. Hepatic lipase promotes a loss of apolipoprotein AI from triglyceride-enriched human high density lipoproteins during incubation in vitro. Arteriosclerosis Thrombosis 1991; 11: 415-22.
39. Reaven GM, Chen Y-DI, Jeppesen J, Maheux P, Krauss RM. Insulin resistance and hyperinsulinaemia in individuals with small, dense, low density lipoprotein particles. J Clin Invest 1993; 92: 141-6.